Nikita M. Volkov
Saint Petersburg, SPE, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Secondary Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome Following Allo-HCT: Features, Outcomes, and Risk Stratification.
Journal: European journal of haematology
Published: February 04, 2026
Interconnection of Gut Microbiome and Efficacy of Immune Checkpoint Inhibitors in Inoperable Non-Small-Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: July 11, 2025
Surgical Removal of Residual Tumor Masses in Patients Undergoing Targeted Therapy for EGFR-Mutated Locally Advanced or Metastatic Lung Cancer.
Journal: International journal of cancer
Published: July 01, 2025
Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients.
Journal: Biology direct
Published: June 09, 2025
Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations.
Journal: Cancers
Published: April 09, 2025
Tumor alkalization therapy: misconception or good therapeutics perspective? - the case of malignant ascites.
Journal: Frontiers in oncology
Published: November 22, 2023
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients.
Journal: International journal of molecular sciences
Published: December 18, 2022
Utility of public knowledge bases for the interpretation of comprehensive tumor molecular profiling results.
Journal: Clinical and experimental medicine
Published: November 11, 2022
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance.
Journal: Current treatment options in oncology
Published: September 06, 2022
Tumor acidity: From hallmark of cancer to target of treatment.
Journal: Frontiers in oncology
Published: June 27, 2022
Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine-bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma.
Journal: International journal of hematology
Published: November 15, 2021
Last Updated: 09/26/2026